Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 5/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.55 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.55 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.38 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.38 |
| ▸ | GNG2 | P59768 | 2/20 | 0.35 |
| ▸ | GNB1 | P62873 | 2/20 | 0.35 |
| ▸ | HSPA1A | P0DMV8 | 1/20 | 0.35 |
| ▸ | HSPA8 | P11142 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6737476 | 0.90 | POLB (0.50) | POLBTDP1CTDSP1APEX1GRM2 | |
| SCHEMBL19285910 | 0.90 | POLB (0.50) | POLBTDP1CTDSP1APEX1GRM2 | |
| SCHEMBL17332189 | 0.87 | POLB (0.43) | POLBTDP1CTDSP1APEX1GRM2 | |
| SCHEMBL106105 | 0.82 | POLB (0.65) | POLBTDP1CTDSP1APEX1GRM2 | |
| SCHEMBL4241116 | 0.80 | POLB (0.38) | POLBTDP1CTDSP1GRM2GRM3 | |
| Hydrochloric Acid SCHEMBL9569081 | 0.79 | POLB (0.62) | POLBTDP1CTDSP1APEX1GRM2 | |
| SCHEMBL15645819 | 0.79 | POLB (0.62) | POLBTDP1CTDSP1APEX1GRM2 | |
| SCHEMBL19688970 | 0.79 | POLB (0.40) | POLBTDP1CTDSP1APEX1GNG2 | |
| SCHEMBL24597758 | 0.77 | POLB (0.43) | POLBTDP1CTDSP1APEX1GRM2 | |
| SCHEMBL2348382 | 0.74 | POLB (0.56) | POLBTDP1CTDSP1APEX1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122037731-A | Wear-resistant waterproof paint and preparation method thereof | 广州和新实业有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-120041967-A | Modified polyimide material, preparation method of battery separator and battery | 广东电网有限责任公司韶关供电局 | 2025-05-27 | — | — | CN | disclosed |
| CN-114479452-B | Large-thickness low-dielectric high-temperature-resistant polyimide composite material and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2024-04-09 | — | — | CN | disclosed |
| CN-114479452-A | Large-thickness low-dielectric high-temperature-resistant polyimide composite material and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2022-05-13 | — | — | CN | disclosed |
| US-7700802-B2 | by utilizing the difference in solubility between a neutralized salt of the endo isomer and a neutral salt of the exo isomer of a dicarboxylic acid having a norbornene or norbornane structure; mixing the above endo and exo mixture with NaOH and a solvent, filtering to separate liquid and solid phase | HITACHI CHEMICAL CO., LTD. (JP) | 2010-04-20 | — | — | US | disclosed |
| US-20070142668-A1 | Method of separating stereoisomers of dicarboxylic acid having norbornene or norbornane structure, or derivative thereof | HITACHI CHEMICAL CO., LTD. (JP) | 2007-06-21 | — | — | US | disclosed |
| EP-1669342-A1 | METHOD OF SEPARATING STEREOISOMERS OF NORBORNENE, DICARBOXYLIC ACID HAVING NORBORNANE STRUCTURE, OR DERIVATIVE THEREOF | Hitachi Chemical Co., Ltd. (JP) | 2006-06-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070142668-A1 | Method of separating stereoisomers of dicarboxylic acid having norbornene or norbornane structure, or derivative thereof | EXOC1, RER1, PRMT8 | POLB 2359/4885TDP1 1005/4885CTDSP1 1201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.